Kiyoshi Migita Selected Research

Chemokines

1/2023	Transcription factor Fli-1 impacts the expression of CXCL13 and regulates immune cell infiltration into the kidney in MRL/lpr mouse.
1/2020	Ets Family Transcription Factor Fli-1 Promotes Leukocyte Recruitment and Production of IL-17A in the MRL/Lpr Mouse Model of Lupus Nephritis.
8/2019	Galectin-9 in autoimmune hepatitis: Correlation between serum levels of galectin-9 and M2BPGi in patients with autoimmune hepatitis.
12/2018	Serum cytokine profiles and Mac-2 binding protein glycosylation isomer (M2BPGi) level in patients with autoimmune hepatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kiyoshi Migita Research Topics

Disease

55	Rheumatoid Arthritis 11/2023 - 02/2004
23	Familial Mediterranean Fever (Periodic Disease) 10/2023 - 05/2013
19	Fever (Fevers) 12/2022 - 06/2012
19	Autoimmune Diseases (Autoimmune Disease) 06/2022 - 12/2003
17	Inflammation (Inflammations) 12/2023 - 02/2004
17	Infections 12/2022 - 04/2005
14	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 05/2020 - 03/2005
13	Adult-Onset Still's Disease 01/2024 - 01/2015
12	Arthritis (Polyarthritis) 10/2023 - 01/2008
10	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2023 - 03/2007
10	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2023 - 01/2012
10	Autoimmune Hepatitis 01/2021 - 07/2007
9	Liver Diseases (Liver Disease) 09/2023 - 01/2006
9	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2006
9	Fibrosis (Cirrhosis) 01/2020 - 04/2006
8	Thrombocytopenia (Thrombopenia) 01/2023 - 04/2009
7	Neoplasms (Cancer) 11/2023 - 05/2002
7	Takayasu Arteritis (Arteritis, Takayasu's) 03/2023 - 01/2014
7	Disease Progression 01/2022 - 01/2007
6	Liver Failure 01/2023 - 03/2005
6	Lupus Nephritis 01/2023 - 01/2014
6	Myositis (Idiopathic Inflammatory Myopathies) 04/2022 - 01/2011
6	Immunoglobulin G4-Related Disease 01/2022 - 01/2012
6	Edema (Dropsy) 01/2022 - 01/2015
6	Rheumatic Diseases (Rheumatism) 12/2021 - 06/2015
6	Hepatitis 11/2019 - 04/2006
6	Hepatocellular Carcinoma (Hepatoma) 01/2011 - 05/2002
5	Melanoma (Melanoma, Malignant) 02/2023 - 06/2008
5	Venous Thrombosis (Deep-Vein Thrombosis) 07/2018 - 04/2009
5	Venous Thromboembolism 04/2018 - 01/2011
4	Synovitis 01/2024 - 02/2004
4	Pain (Aches) 10/2023 - 09/2020
4	Pancytopenia 01/2023 - 01/2016
4	Vasculitis (Vasculitides) 01/2023 - 01/2010
4	Dermatomyositis (Dermatopolymyositis) 04/2022 - 01/2011
4	Systemic Scleroderma (Systemic Sclerosis) 11/2020 - 01/2016
4	Osteoarthritis 04/2018 - 02/2004
4	Jaundice (Icterus) 01/2018 - 01/2007
4	Hepatitis B 03/2016 - 04/2005
3	Amyopathic dermatomyositis 01/2024 - 03/2019
3	Proteinuria 03/2023 - 01/2014
3	Amyloidosis 01/2023 - 05/2002
3	Muscle Weakness 04/2022 - 01/2015

Drug/Important Bio-Agent (IBA)

24	AntibodiesIBA 02/2023 - 09/2003
23	CytokinesIBA 01/2024 - 02/2004
19	Colchicine FDA LinkGeneric 10/2023 - 01/2014
18	SteroidsIBA 12/2022 - 09/2006
15	AutoantibodiesIBA 03/2024 - 12/2003
15	tocilizumab (atlizumab)FDA Link 03/2023 - 08/2011
14	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024 - 01/2005
12	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 01/2008
12	Interleukin-6 (Interleukin 6)IBA 01/2023 - 04/2005
12	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022 - 11/2006
11	Immunoglobulin G (IgG)IBA 03/2024 - 01/2011
10	Biomarkers (Surrogate Marker)IBA 10/2021 - 09/2011
9	Tacrolimus (Prograf)FDA LinkGeneric 01/2022 - 04/2006
8	EnzymesIBA 08/2023 - 12/2003
8	GlucocorticoidsIBA 03/2023 - 08/2011
8	Prednisolone (Predate)FDA LinkGeneric 12/2022 - 06/2012
8	InflammasomesIBA 12/2022 - 01/2014
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2006
7	canakinumab FDA Link 10/2023 - 11/2019
7	AA amyloidosisIBA 03/2023 - 05/2002
7	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2022 - 01/2011
7	Serum Amyloid A Protein (Serum Amyloid A)IBA 03/2021 - 05/2002
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2023 - 01/2005
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 01/2002
6	PyrinIBA 12/2022 - 01/2008
6	Proteins (Proteins, Gene)FDA Link 12/2022 - 11/2015
6	C-Reactive ProteinIBA 03/2021 - 01/2015
6	Interleukin-18 (Interleukin 18)IBA 09/2020 - 02/2004
5	Amyloid (Amyloid Fibrils)IBA 01/2023 - 11/2006
5	Immunoglobulins (Immunoglobulin)IBA 06/2022 - 01/2017
5	HLA Antigens (Human Leukocyte Antigens)IBA 11/2019 - 01/2012
5	Alanine Transaminase (SGPT)IBA 08/2019 - 01/2011
5	Heparin (Liquaemin)FDA LinkGeneric 04/2018 - 04/2009
4	Immunoglobulin M (IgM)IBA 03/2024 - 08/2011
4	AntigensIBA 01/2024 - 03/2006
4	Carrier Proteins (Binding Protein)IBA 01/2024 - 12/2018
4	NucleotidesIBA 11/2023 - 01/2019
4	Janus Kinase InhibitorsIBA 07/2023 - 05/2011
4	Interleukin-1 (Interleukin 1)IBA 06/2023 - 01/2021
4	ChemokinesIBA 01/2023 - 12/2018
4	LigandsIBA 01/2023 - 02/2010
4	InterferonsIBA 11/2022 - 01/2011
4	Anti-Citrullinated Protein AntibodiesIBA 01/2022 - 01/2020
4	ImmunosorbentsIBA 01/2022 - 12/2003
4	Methylprednisolone FDA LinkGeneric 12/2021 - 01/2015
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 01/2015
4	BilirubinIBA 08/2019 - 01/2006
4	Polysaccharides (Glycans)IBA 01/2018 - 06/2015
3	Complement System Proteins (Complement)IBA 12/2023 - 01/2011
3	tofacitinibIBA 07/2023 - 01/2020
3	Monoclonal AntibodiesIBA 06/2023 - 09/2022
3	Messenger RNA (mRNA)IBA 01/2023 - 06/2008
3	Ferritins (Ferritin)IBA 12/2022 - 01/2020
3	Immunoglobulin A (IgA)IBA 01/2022 - 10/2021

Therapy/Procedure

34	Therapeutics 01/2024 - 01/2005
6	Knee Replacement Arthroplasty (Total Knee Replacement) 05/2017 - 04/2009
4	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2022 - 04/2009